David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
CALL
Fair Isaac
FICO
$24.6B
| $908K | ﹤0.01% |
10,000
| – | – |
|
|
2752
PUT
Fair Isaac
FICO
$24.6B
| $908K | ﹤0.01% |
+10,000
| New | +$897K |
|
2753
CALL
Truist Financial
TFC
$61.4B
| $907K | ﹤0.01% |
22,500
| – | – |
|
|
BPMC
2754
DELISTED
Blueprint Medicines
BPMC
| $906K | ﹤0.01% |
+34,191
| New | +$976K |
|
2755
CBIZ
CBZ
$2.97B
| $905K | ﹤0.01% |
93,845
-1,216
| -1% | -$11.4K |
|
|
SSRG
2756
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $905K | ﹤0.01% |
103,783
-3,422
| -3% | -$28.2K |
|
2757
Antero Resources
AR
$11.7B
| $898K | ﹤0.01% |
26,157
-8,041
| -24% | -$319K |
|
2758
PUT
HSBC
HSBC
$358B
| $896K | ﹤0.01% |
+22,447
| New | +$935K |
|
2759
Huazhu Hotels Group
HTHT
$15.2B
| $895K | ﹤0.01% |
+146,548
| New | +$883K |
|
2760
Novartis
NVS
$304B
| $893K | ﹤0.01% |
10,132
-3,260
| -24% | -$299K |
|
2761
Descartes Systems
DSGX
$6.64B
| $891K | ﹤0.01% |
55,500
-15,100
| -21% | -$234K |
|
2762
iShares Russell 2000 ETF
IWM
$81.7B
| $890K | ﹤0.01% |
7,126
+2,000
| +39% | +$250K |
|
|
DNR
2763
PUT
DELISTED
Denbury Resources, Inc.
DNR
| $890K | ﹤0.01% |
140,000
-90,000
| -39% | -$686K |
|
2764
Digi International
DGII
$2.88B
| $889K | ﹤0.01% |
93,109
+24,285
| +35% | +$237K |
|
|
BDSI
2765
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $888K | ﹤0.01% |
111,561
+88,350
| +381% | +$759K |
|
2766
Kinder Morgan
KMI
$68.9B
| $885K | ﹤0.01% |
+23,039
| New | +$962K |
|
|
LHO
2767
DELISTED
LaSalle Hotel Properties
LHO
| $885K | ﹤0.01% |
24,944
-20,722
| -45% | -$765K |
|
|
LTXB
2768
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $884K | ﹤0.01% |
+29,258
| New | +$768K |
|
2769
Aon
AON
$75.3B
| $881K | ﹤0.01% |
8,835
-172,031
| -95% | -$17.2M |
|
2770
Sun Communities
SUI
$15.3B
| $881K | ﹤0.01% |
+14,248
| New | +$903K |
|
2771
Inovio Pharmaceuticals
INO
$133M
| $879K | ﹤0.01% |
8,979
+232
| +3% | +$24.8K |
|
|
NOR
2772
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $878K | ﹤0.01% |
147,514
+45,540
| +45% | +$730K |
|
|
CTXS
2773
PUT
DELISTED
Citrix Systems Inc
CTXS
| $877K | ﹤0.01% |
15,698
+3,140
| +25% | +$167K |
|
|
STI
2774
DELISTED
SunTrust Banks, Inc.
STI
| $877K | ﹤0.01% |
+20,379
| New | +$866K |
|
|
RPRX
2775
DELISTED
Repros Therapeutics Inc.
RPRX
| $877K | ﹤0.01% |
122,723
+56,142
| +84% | +$437K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.